Home Press Release Point Of Care Molecular Diagnostics Market Size Projected to Reach $14.92 billion by 2034 | 6.23%

Point Of Care Molecular Diagnostics Market Size Projected to Reach $14.92 billion by 2034 | 6.23%

23 Jul, 2026

According to Straits Research the global point-of-care molecular diagnostics market size was valued at $8.69 billion in 2025 and is expected to grow from $9.20 billion in 2026 to $14.92 billion by 2034, registering a CAGR of 6.23% during the forecast period 2026–2034.

The rising need for faster and accurate results from molecular tests and the increasing number of clinical studies to determine the efficiency and accuracy of novel molecular tests propel market growth.

Segment Analysis

Market Drivers

  • Technological advancements, new product development, and increasing demand for point-of-care molecular diagnostic services drive the market.
  • The rising prevalence of infectious diseases and genetic disorders worldwide; as per the World Health Organization (WHO), over 17 million people die due to infectious diseases every year.

Regional Analysis

Key Insights

  • North America is projected to dominate the point-of-care molecular diagnostic market during the forecast period. The increasing prevalence of chronic diseases and acute disorders, technological advancements, and the presence of well-established healthcare industries drive the regional market.
  • Asia-Pacific’s point-of-care molecular diagnostic market is expected to grow at the highest CAGR due to the increasing number of hospitals and diagnostic laboratories and rising accessibility of healthcare.
  • The test-kits segment is projected to dominate the point-of-care molecular diagnostic market due to the frequent use of test kits for the diagnosis of various diseases.
  • By the end-user, the decentralized laboratories segment is projected to dominate the point-of-care molecular diagnostic market.

 

Market Segments

  1. By Product Type
    1. Analyzers
    2. Test Kit
    3. Bacterial
    4. Fungal
    5. Viral
  2. By Technology
    1. PCR
    2. Genetic sequencing
    3. Hybridization
    4. Micro-array
  3. By End-User
    1. Decentralized laboratories
    2. Hospital
    3. Homecare
    4. Assisted living healthcare facilities